Skip to main content
OpenTrials
Completed

NCT Number: NCT01378689

Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids

This quality improvement project is aimed at improving health care by identifying low cost strategies to get Rheumatoid Arthritis (RA) patients to more effectively communicate with their physicians about osteoporosis prevention and treatment (improving doctor-patient communication). The investigators will implement a direct to patient intervention to the population of interest (patients on chronic glucocorticoids) via story-telling, using an Internet based video. The target audience is people on chronic glucocorticoids not already receiving bones-specific osteoporosis medications to determine differences in post-intervention rates of osteoporosis care, and the rates of prescription anti-osteoporosis therapies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adverse Effect of Glucocorticoids and Synthetic Analogues Arthritis Arthritis, Rheumatoid Autoimmune Diseases Bone Diseases Bone Diseases, Metabolic Connective Tissue Diseases Immune System Diseases Joint Diseases Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases Osteoporosis Rheumatic Diseases Rheumatoid Arthritis Skin and Connective Tissue Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Greater than or equal to 5 milligrams of prednisone or glucocorticoid dose equivalent for greater than or equal to 90 days within the previous 12 months
  • Medco member for entire study period
  • Refill steroid prescription online

Exclusion criteria

  • anti-osteoporosis medication in previous 12 months

Treatment and study plan

Storytelling online video

Other

patients with a history of chronic glucocorticoids use tell their experiences of side effects resulting from chronic use and provide advice on ways to prevent side effects

Primary outcomes

  1. Number of participants receiving Anti-osteoporosis Treatment

    Time frame: within 3 - 12 months of exposure to video

    Includes bisphosphonates, PTH, SERM, Calcitonin

Secondary outcomes

  1. Calcium and Vitamin D use

    Time frame: within 3 - 12 months of exposure to video

    Are participants taking calcium and vitamin d supplements

  2. Patient-Physician Communication

    Time frame: within 3 - 12 months of exposure to video

    Did viewing the video increase patient-physician communication

Sponsors and collaborators

Lead sponsor

University of Alabama at Birmingham

Other

Collaborators

  • Medco Health Services, Inc

Registry information

Official study title

Improving Bone Health Among RA Patients on Chronic Glucocorticoids

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Jun 22, 2011
Registry last updated
Jan 16, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.